Dr. Hamid R. Mirshahidi, MD
- Medicare services, 2024
- 979
- Medicare patients, 2024
- 234
- Part D claims, 2024
- 668
- Publications
- 38
- Clinical trials
- 8
- Practice address
- 11234 Anderson St, Loma Linda, CA 92354
- Practice phone
- Call (909) 558-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mirshahidi's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Hamid R. Mirshahidi is a medical oncologist in Loma Linda, California
Dr. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church.
Dr. Mirshahidi's NPI, 1659307015, was assigned on June 25, 2006. Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992. Dr. Mirshahidi holds California license A80969.
- NPI
- 1659307015NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2769418664
- NPI enumeration date
- June 25, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (909) 558-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 60
- Medical school graduation
- 1992
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Hamid R. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California
Dr. Mirshahidi's primary practice is Loma Linda University Medical Center, at 11234 Anderson St, Loma Linda, CA 92354 in San Bernardino County. The practice phone is (909) 558-4000.
- Loma Linda University Medical Center11234 Anderson St, Loma Linda, CA 92354 · San Bernardino CountyPhone(909) 558-4000
Source: Dmand AI Affiliation Data
Dr. Hamid R. Mirshahidi is affiliated with 2 sites of care and 1 medical group
Dr. Mirshahidi's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Mirshahidi to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Hamid R. Mirshahidi's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirshahidi practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Loma Linda University Medical Center | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Seventh-day Adventist Church and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Hamid R. Mirshahidi is one of 415 medical oncologists in California
Medical oncology is Dr. Mirshahidi's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mirshahidi is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Mirshahidi's licenses on file in 3 states: California, Michigan and West Virginia.
Specialties and state licenses
- Medical oncology, CaliforniaPrimary
- Michigan license
- West Virginia license
Clinical focus
Dmand AI lists breast cancer, chronic anemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and purpura and thrombocytopenia among the conditions Dr. Mirshahidi treats.
Medical oncologists near Dr. Mirshahidi
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Hamid R. Mirshahidi billed Medicare for 979 services in 2024
CMS data shows 979 Medicare services from Dr. Mirshahidi across 6 procedure codes in 2024, for 234 Medicare patients. Medicare paid $48,076 for them.
Dr. Mirshahidi's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 5962024: 5813%
- Other services
- 2023: 02024: 398
Where Dr. Mirshahidi's Medicare services took place, 2024
- In an office333%
- In a facility94697%
Dr. Mirshahidi compared with the California median for medical oncologists, 2024
- Dr. Mirshahidi
- California median
- Medicare services
- 979vs 49697% above
- Medicare patients
- 234vs 15452% above
- Part D claims
- 526vs 1443.7 times
Medians across 358 medical oncologists in California with Dmand AI profiles that report each measure.
Dr. Mirshahidi's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mirshahidi?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mirshahidi and other medical oncologists in California.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Hamid R. Mirshahidi treated 234 Medicare patients in 2024, average age 72
CMS counts 234 Medicare patients who saw Dr. Mirshahidi in 2024. The largest group is 65 to 74, with 108 patients. 73% of them have high blood pressure, and 72% have cancer. 38% are also on Medicaid. Their average risk score is 2.46, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mirshahidi's median patient age at 67, with 66% women.
Dr. Mirshahidi's Medicare patients by age, 2024
Dr. Mirshahidi's Medicare patients by sex, 2024
- Women15767%
- Men7733%
Chronic conditions among Dr. Mirshahidi's Medicare patients, 2024
- High blood pressure73%
- Cancer72%
- High cholesterol65%
- Arthritis45%
- Diabetes39%
- Chronic kidney disease28%
- COPD26%
- Ischemic heart disease26%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mirshahidi's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 67
Patient panel by sex, all payers
- Women66%
- Men33%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Hamid R. Mirshahidi wrote 668 Medicare Part D claims in 2024
In 2024, Dr. Mirshahidi wrote 668 Medicare Part D claims for 116 patients. 74% of them were for generic drugs. CMS names the drug for 526 of them, across 16 drugs with 11 or more claims each, at $1,825,681 in total drug cost. In 2023, CMS named 454 claims across 10 drugs.
Dr. Mirshahidi's Part D claims by kind of drug, 2024
- Generic497 claims74%
- Brand-name171 claims26%
Dr. Mirshahidi's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Mirshahidi's Part D claims, 2024
- Antibiotics2%15 of 668 claims
- Antipsychotics, patients 65 and over2%14 of 668 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4542024: 52616%
Drugs named by CMS: 16 in 2024, 10 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Hamid R. Mirshahidi scored 89 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Mirshahidi for performance year 2024, reported as part of a group. Dr. Mirshahidi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mirshahidi as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mirshahidi's MIPS scores, performance year 2024
- 89of 100Final score
- 72.1of 100Quality
- 80of 100Promoting Interoperability
- 40of 100Improvement Activities
- 77of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Hamid R. Mirshahidi has 38 publications on record
Dmand AI links 38 papers to Dr. Mirshahidi, published from 2010 to 2025. 2021 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Dr. Mirshahidi has published most often in Exp Hematol Oncol. Dr. Mirshahidi's most frequent co-authors are Anthony Loc Nguyen, MD, David Baylink, MD and Joel M. Brothers, MD.
Dr. Mirshahidi's papers by year, 2010 to 2025
Topics Dr. Mirshahidi writes about most
- Breast Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Protein Kinase Inhibitors
- Anaplastic Lymphoma Kinase
- Disease Progression
Dr. Mirshahidi's most frequent co-authors
- Anthony Loc Nguyen, MD5 shared papers
- David Baylink, MD2 shared papers
- Joel M. Brothers, MD2 shared papers
Recent publications by Dr. Mirshahidi
Clin Lymphoma Myeloma Leuk
J Oncol Pharm Pract
See who Dr. Mirshahidi researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mirshahidi works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Hamid R. Mirshahidi has worked on 8 clinical trials
Dmand AI links Dr. Mirshahidi to 8 clinical trials, 2 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Small Cell Lung Carcinoma, Carcinoma, Bronchogenic and Carcinoma, Non-Small-Cell Lung. SWOG Cancer Research Network sponsors the most, 5.
Clinical trials with Dr. Mirshahidi by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Mirshahidi's trials
- Small Cell Lung Carcinoma
- Carcinoma, Bronchogenic
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Small Cell
- Carcinoma, Neuroendocrine
Investigators on the most trials with Dr. Mirshahidi
- Lyudmila A. Bazhenova, MD5 shared trials
- Shadia I. Jalal, MD5 shared trials
- Marianna Koczywas, MD5 shared trials
Recent clinical trials with Dr. Mirshahidi
Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC (opens in a new tab)
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Hamid R. Mirshahidi received $81,817 in industry payments from 2016 to 2025
CMS Open Payments shows 127 general payments to Dr. Mirshahidi from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Merck Sharp & Dohme Corporation paid the most, $47,992. It also lists 1 research payment totaling $3,770 in 2019.
General payments to Dr. Mirshahidi by program year, 2016 to 2025
General payments to Dr. Mirshahidi by kind, 2016 to 2025
- Speaker and faculty fees$41,40551%
- Consulting fees$25,71331%
- Travel and lodging$7,7229%
- Food and beverage$3,6254%
- Other$3,3534%
Companies that paid Dr. Mirshahidi the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Hamid R. Mirshahidi has 3 awards and honors on record
Dmand AI lists 3 awards for Dr. Mirshahidi, most recently CMS Stage 1 EHR in 2013.
Awards and honors for Dr. Mirshahidi
- 2013
- CMS Stage 1 EHR
- 2008
- Best Doctors in Inland Empire
- 2005
- Margaret J. Albrink Research Award
Source: Dmand AI Professional Profile Data
Dr. Hamid R. Mirshahidi graduated from Marmara Univ- Fac Med
Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992.
- Medical school
- Board certified in hematology
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Hamid R. Mirshahidi accepts plans from 17 insurance carriers
Dr. Mirshahidi is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Elevance
- Aetna
- Excellus BlueCross BlueShield
- Blue Cross Blue Shield of Michigan
- United Healthcare
- HCSC
- Blue Cross Blue Shield of Massachusetts
- Molina
- +9 more carriersWith a free account
Plan types Dr. Mirshahidi accepts, by number of carriers
- Medicare10
- PPO10
- HMO8
- POS6
- EPO5
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Hamid R. Mirshahidi's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Hamid R. Mirshahidi
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Hamid R. Mirshahidi's NPI number?
Dr. Hamid R. Mirshahidi's NPI number is 1659307015. It was assigned on June 25, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Hamid R. Mirshahidi?
Dr. Hamid R. Mirshahidi is a medical oncologist in Loma Linda, California. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Hamid R. Mirshahidi practice?
Dr. Mirshahidi practices at 11234 Anderson St, Loma Linda, CA 92354. Dr. Mirshahidi's primary practice is Loma Linda University Medical Center in Loma Linda, California, part of Seventh-day Adventist Church. Dmand AI also links Dr. Mirshahidi to 1 group practice or clinic.
What is Dr. Hamid R. Mirshahidi's office phone number?
The practice phone on file for Dr. Mirshahidi is (909) 558-4000.
What is Dr. Hamid R. Mirshahidi's medical license number?
Dr. Mirshahidi holds California license A80969, one of the licenses on file in 3 states.
Which states has Dr. Hamid R. Mirshahidi been licensed in?
Dmand AI has state licenses on file for Dr. Mirshahidi in California (2002 to 2026), Michigan (1999 to 2018) and West Virginia (2002 to 2017).
Which hospitals is Dr. Hamid R. Mirshahidi affiliated with?
Dr. Mirshahidi practices at Loma Linda University Medical Center in Loma Linda, California.
What medical group is Dr. Hamid R. Mirshahidi part of?
Dr. Mirshahidi is linked to Loma Linda University Faculty Medical Group (LLUFMG).
Does Dr. Hamid R. Mirshahidi accept Medicare?
Yes. CMS data shows Dr. Mirshahidi billed Medicare for 979 services in 2024, and Dr. Mirshahidi accepts Medicare assignment.
Does Dr. Hamid R. Mirshahidi offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mirshahidi as offering telehealth services.
Show 11 more questionsShow fewer questions
What is Dr. Hamid R. Mirshahidi's MIPS score?
Dr. Mirshahidi's MIPS final score for performance year 2024 is 89 out of 100, reported as part of a group.
How many Medicare patients does Dr. Hamid R. Mirshahidi see?
CMS counts 234 Medicare patients who saw Dr. Mirshahidi in 2024, with an average age of 72.
Is Dr. Hamid R. Mirshahidi board certified?
Yes. Dr. Mirshahidi is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Hamid R. Mirshahidi bill to Medicare?
In 2024, Dr. Mirshahidi's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99215).
Where did Dr. Hamid R. Mirshahidi go to medical school?
Dr. Mirshahidi graduated from Marmara Univ- Fac Med in 1992.
What drugs does Dr. Hamid R. Mirshahidi prescribe most?
In 2024 Medicare Part D data, Dr. Mirshahidi's most prescribed drugs by claims were Anastrozole, Tagrisso and Letrozole.
Has Dr. Hamid R. Mirshahidi received payments from drug or device companies?
CMS Open Payments shows $81,817 in general payments to Dr. Mirshahidi from 26 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.
How long has Dr. Hamid R. Mirshahidi been practicing?
Dr. Mirshahidi graduated from medical school in 1992, 34 years ago.
Does Dr. Hamid R. Mirshahidi do research?
Dmand AI links 38 publications to Dr. Mirshahidi, published from 2010 to 2025. Dr. Mirshahidi has worked on 8 clinical trials.
Who does Dr. Hamid R. Mirshahidi publish with?
Dr. Mirshahidi's most frequent co-authors are Anthony Loc Nguyen, MD (5 shared papers), David Baylink, MD (2 shared papers) and Joel M. Brothers, MD (2 shared papers).
What insurance does Dr. Hamid R. Mirshahidi accept?
Dr. Mirshahidi is in network with 17 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card